Keyphrases
Antipsychotics
87%
Nave
68%
Healthy Controls
53%
Cerebral Blood Flow
51%
Functional Magnetic Resonance Imaging
51%
Schizophrenic Patients
49%
First-episode Psychosis
38%
Glutamate
34%
White Matter Hyperintensities
33%
Schizophrenia
33%
Magnetic Resonance Imaging
29%
White Matter
22%
Psychosis
20%
Leukoaraiosis
20%
Regional Cerebral Blood Flow (rCBF)
19%
Perfusion
18%
Resting Cerebral Blood Flow
17%
Disability Studies
17%
Patients with Schizophrenia
16%
Cerebral Perfusion
16%
Visual Stimulation
15%
Dopamine D2/3 Receptor
15%
Migraine without Aura (MWoA)
15%
Corpus Callosum Dysgenesis
15%
Multiple Sclerosis
15%
Positron Emission Tomography
15%
Age-related White Matter Changes
15%
Anterior Cingulate Cortex
14%
Corpus Callosum
14%
Striatal
14%
Psychopathology
13%
Cognitive Function
13%
Receptor Blockade
13%
Psychotic Symptoms
13%
Positive Symptoms
13%
Electroconvulsive Therapy
12%
Ultra-high Risk for Psychosis
12%
γ-aminobutyric Acid
12%
Healthy Volunteers
12%
Fractional Anisotropy
11%
Amisulpride
11%
Disability
11%
Elderly People
11%
Clinical Outcomes
11%
White Matter Changes
10%
Visual Cortex
10%
Clinical Correlation
10%
Small Vessel Disease
10%
Control Subjects
10%
Arterial Spin Labeling
10%
Neuroscience
Antipsychotic
100%
Dementia Praecox
93%
Functional Magnetic Resonance Imaging
65%
Magnetic Resonance Imaging
51%
Magnetic Resonance Imaging
37%
Glutamic Acid
34%
Longitudinal Study
29%
Cognitive Disorders
28%
Gray Matter
27%
Gamma-Aminobutyric Acid
25%
Positive Syndrome
23%
Cognitive Function
22%
Thalamus
20%
Leukoaraiosis
19%
Migraine
19%
Arterial Spin Labeling
16%
Negative Syndrome
16%
Fractional Anisotropy
16%
Anterior Cingulate Cortex
15%
Positron Emission Tomography
15%
Multiple Sclerosis
15%
Corpus Callosum
14%
Eicosanoid Receptor
14%
Psychosis
14%
Functional Connectivity
13%
Auras
13%
Reward System
12%
Temporal Lobe
12%
Electroconvulsive Therapy
12%
Placebo
12%
Putamen
11%
Amisulpride
11%
Visual Cortex
10%
Diffusion MRI
10%
Diffusion Tensor Imaging
10%
Electroencephalography
9%
Posttraumatic Stress Disorder
9%
Optic Neuritis
9%
Neurotrauma
9%
Traumatic Brain Injury
9%
Tadalafil
9%
Antidepressant
9%
Hippocampus
8%
Muscular Dystrophy
8%
Brain Lesion
8%
Randomized Controlled Trial
8%
Metabolic Pathway
8%
Frontal Lobe
7%
Cerebrovascular Disease
7%
Striatum
7%